Nifty
Sensex
:
:
11745.30
40043.38
-144.10 (-1.21%)
-478.72 (-1.18%)

Pharmaceuticals & Drugs

Rating :
N/A  (View)

BSE: 533211 | NSE: PARABDRUGS

2.22
-0.06 (-2.63%)
27-Oct-2020 | 3:41PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  2.22
  •  2.22
  •  2.22
  •  2.28
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  700
  •  0.02
  •  4.73
  •  1.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13.74
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 995.90
  • N/A
  • -0.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 37.79%
  • 1.87%
  • 43.60%
  • FII
  • DII
  • Others
  • 8.06%
  • 0.00%
  • 8.68%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.02
  • -0.02
  • -0.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -32.41
  • -53.34
  • -80.73

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
73
75
77
232
438
767
924
620
514
Net Sales Growth
-
-2%
-3%
-67%
-47%
-43%
-17%
49%
21%
 
Cost Of Goods Sold
-
64
93
329
256
368
767
693
448
364
Gross Profit
-
9
-18
-252
-24
70
0
232
172
150
GP Margin
-
13%
-24%
-328%
-10%
16%
0%
25%
28%
29%
Total Expenditure
-
102
153
428
361
570
883
767
508
431
Power & Fuel Cost
-
7
9
10
15
17
10
10
6
4
% Of Sales
-
9%
12%
13%
7%
4%
1%
1%
1%
1%
Employee Cost
-
10
9
11
17
19
24
23
17
14
% Of Sales
-
13%
12%
14%
8%
4%
3%
2%
3%
3%
Manufacturing Exp.
-
3
4
5
9
12
16
19
19
20
% Of Sales
-
4%
6%
6%
4%
3%
2%
2%
3%
4%
General & Admin Exp.
-
3
2
4
6
10
10
9
6
5
% Of Sales
-
4%
3%
6%
2%
2%
1%
1%
1%
1%
Selling & Distn. Exp.
-
3
3
4
8
10
14
13
12
9
% Of Sales
-
4%
4%
6%
3%
2%
2%
1%
2%
2%
Miscellaneous Exp.
-
13
32
65
50
134
42
1
0
14
% Of Sales
-
18%
43%
84%
21%
31%
5%
0%
0%
3%
EBITDA
-
-29
-78
-351
-129
-132
-117
157
112
83
EBITDA Margin
-
-40%
-105%
-457%
-55%
-30%
-15%
17%
18%
16%
Other Income
-
4
6
0
1
13
6
4
15
5
Interest
-
9
11
108
99
84
73
64
41
38
Depreciation
-
22
22
23
24
19
17
31
18
6
PBT
-
-56
-105
-481
-250
-222
-201
66
69
44
Tax
-
2
3
4
130
-88
-56
15
17
10
Tax Rate
-
-3%
-3%
-1%
-52%
40%
28%
23%
24%
22%
PAT
-
-58
-108
-486
-380
-134
-144
51
52
34
PAT before Minority Interest
-
-58
-108
-486
-380
-134
-144
51
52
34
Minority Interest
-
0
0
0
0
0
0
0
0
0
PAT Margin
-
-79%
-144%
-632%
-164%
-31%
-19%
6%
8%
7%
PAT Growth
-
47%
78%
-28%
-184%
7%
-382%
-2%
52%
 
EPS
-
-9.30
-17.46
-78.47
-61.46
-21.62
-23.32
8.27
8.40
5.53

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
-855
-798
-690
-204
176
296
428
379
159
Share Capital
62
62
62
62
62
62
62
62
37
Total Reserves
-943
-886
-778
-292
88
222
367
317
121
Non-Current Liabilities
870
868
760
588
429
378
161
104
428
Secured Loans
801
801
697
531
502
389
129
92
395
Unsecured Loans
34
35
33
31
30
31
17
0
26
Long Term Provisions
1
1
2
2
3
3
3
2
0
Current Liabilities
394
413
498
559
510
520
726
584
103
Trade Payables
81
106
93
102
189
124
284
177
88
Other Current Liabilities
165
164
163
61
12
36
50
30
8
Short Term Borrowings
148
143
242
396
309
360
376
359
0
Short Term Provisions
0
0
0
0
0
0
15
17
7
Total Liabilities
409
484
569
943
1,116
1,194
1,315
1,067
690
Net Block
326
349
371
395
331
334
188
163
130
Gross Block
481
483
484
486
398
382
220
185
144
Accumulated Depreciation
155
134
112
91
68
49
32
22
14
Non Current Assets
333
355
378
402
413
407
544
372
173
Capital Work in Progress
7
7
7
7
82
73
192
115
43
Non Current Investment
0
0
0
0
0
0
0
3
0
Long Term Loans & Adv.
0
0
0
0
0
0
0
0
0
Other Non Current Assets
0
0
0
0
0
0
164
91
0
Current Assets
74
113
144
450
565
606
771
695
480
Current Investments
0
0
0
0
0
0
0
0
0
Inventories
16
15
40
316
368
352
452
341
240
Sundry Debtors
29
67
70
98
149
139
222
275
193
Cash & Bank
1
1
1
3
6
13
35
26
18
Other Current Assets
28
0
0
0
42
102
63
54
29
Short Term Loans & Adv.
28
30
33
32
42
101
62
54
18
Net Current Assets
-320
-300
-354
-109
55
86
45
111
377
Total Assets
409
484
569
943
1,116
1,194
1,315
1,067
690

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
3
3
90
-3
31
-119
208
2
-31
PBT
-56
-105
-481
-250
-222
-201
66
69
44
Adjustment
43
64
175
172
152
125
95
58
48
Changes in Working Capital
16
44
396
74
74
-44
60
-110
-116
Cash after chg. in Working capital
3
3
90
-3
4
-119
222
17
-23
Interest Paid
0
0
0
0
0
0
0
0
0
Tax Paid
0
0
0
0
27
0
-13
-15
-7
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
1
0
1
-16
-30
-102
-206
-180
-87
Net Fixed Assets
2
1
3
-13
-25
-47
-110
-113
Net Investments
0
0
0
0
0
-3
2
-4
Others
-1
0
-1
-3
-5
-52
-98
-64
Cash from Financing Activity
-4
-4
-94
16
-8
199
7
186
122
Net Cash Inflow / Outflow
0
0
-2
-3
-7
-21
9
8
4
Opening Cash & Equivalents
1
1
3
6
13
35
26
18
14
Closing Cash & Equivalent
1
1
1
3
6
13
35
26
18

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
-143
-136
-123
-52
2
16
69
61
32
ROA
-13%
-21%
-64%
-37%
-12%
-12%
4%
6%
5%
ROE
0%
0%
0%
0%
-234%
-54%
13%
21%
28%
ROCE
-32%
-47%
-83%
-20%
-16%
-14%
14%
16%
15%
Fixed Asset Turnover
0.15
0.16
0.18
0.55
1.16
2.77
5.04
4.13
3.88
Receivable days
239
335
359
186
116
79
89
126
126
Inventory Days
78
135
759
513
289
176
142
156
157
Payable days
312
259
93
163
128
87
106
93
76
Cash Conversion Cycle
5
211
1,024
536
277
168
125
189
206
Total Debt/Equity
-1.11
-1.17
-1.27
-2.98
66.92
7.66
1.29
1.25
3.48
Interest Cover
-5
-9
-3
-2
-2
-2
2
3
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.